Word: nih
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...about the use of stem cells already extracted from discarded embryos. There was still a problem. Bush and his advisers were being told there were probably a dozen, maybe 20, such lines--not enough, many scientists said, to sustain the necessary research. But the Aug. 2 meeting with the NIH scientists lifted that cloud. They told Bush there were more than 65 lines available worldwide--not as many as scientists would like but enough for a plausible compromise...
Bush continued to seek views from everywhere. On an Air Force One flight to Philadelphia a few months ago, G.O.P. moderate Senator Arlen Specter of Pennsylvania presented the case for a bill he had sponsored that would fund and control stem-cell research through the NIH. Bush listened attentively but gave no hint of what he thought. On July 11, Bush met with medical leaders to talk about the patients' bill of rights. Toward the end of the meeting, he broke away from health care to tell his audience that "the issue I am wrestling with is stem cells...
...monitor stem-cell research and recommend guidelines.) At the July meeting, the two ethicists reinforced Bush's growing conviction that he should not fund research on newly extracted stem-cell colonies. Now it only remained for him to find a way to make the narrower compromise work. When the NIH discovered the larger number of existing stem cells, the shape of the policy was locked...
...National Institutes of Health that arrived at the 60 figure, conducting a worldwide survey of labs to determine which ones had viable cell lines already in inventory. As recently as last month, the NIH put the figure at just 30, but after what a senior Administration official described as an "arduous process" of searching, the number doubled...
...White House insists that procedures are in place to deal with just this concern--in the form of so-called material transfer agreements, under which the NIH will negotiate with patent holders for access to their cell lines. "Obviously, in any area of medical or scientific research," says the Administration official, "there are companies that get out in front of the technology, and they get the patents...